Pepper patch vs. pill: new hope for cancer nerve pain?
NCT ID NCT04704453
First seen Apr 20, 2026 · Last updated May 02, 2026 · Updated 3 times
Summary
This study tested a capsaicin patch (Qutenza) against a standard nerve pain pill (amitriptyline) in 13 people who had head and neck cancer and still had nerve pain after treatment. The goal was to see if the patch could lower pain by at least 2 points on a 0-10 scale over 9 months. The patch is applied to the face and neck every 3 months, offering a potential alternative to daily medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Saint-Joseph
Marseille, 13285, France
-
INSTITUT DE CANCEROLOGIE DE L'OUEST (ICO) Site Angers
Angers, France
-
Institut Sainte-Catherine
Avignon, France
-
Institut Universitaire du Cancer Toulouse - Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.